Billy Michael Chelliah Jebaraj

6PUBLICATIONS
32CO-AUTHORS
Molecular targetsHaematological tumoursMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 09, 2026
PLCG2 Exon-Skipped Variants: Insights into Their Potential Role in Chronic Lymphocytic Leukemia.

|Apr 23, 2026
The spectrum of immunoglobulin heavy chain enhancer hijacking in chronic lymphocytic leukemia.

|Dec 12, 2025
Overcoming BTK Inhibitor Resistance in Chronic Lymphocytic Leukemia by Targeting PKCβ.

Billy Michael Chelliah Jebaraj, Stephan Stilgenbauer

|Apr 06, 2023
Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia.

Qu Jiang, Johanna Stachelscheid, Johannes Bloehdorn

|Jan 20, 2023
Acquired BTK mutations associated with resistance to noncovalent BTK inhibitors.

Jialei Qi, Sascha Endres, Deyan Yordanov Yosifov

|Oct 18, 2021
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia.

Billy Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan

Pageof 1

Frequent Collaborators

3 joint publications

Jialei Qi

3 joint publications

Sascha Endres

3 joint publications

Peter Gierschik

2 joint publications

Deyan Yordanov Yosifov